Stockmarkets

Markets: interest rate cut boosts FTSE 100

The FTSE 100 saw a sharp rise yesterday after the Bank of England cut interest rates to 0.25% and extended its quantitative easing programme. The index closed up 1.6% at 6,740.

What is the yield curve saying?

An inverted yield curve usually means a recession lies ahead. Is this time different? And does it matter? John Stepek explains.

British banks should stop fretting about Brexit

British banks should be bolder and go looking for new opportunities in Europe, says Matthew Lynn.

The charts that matter: have recession rumours been overstated?

With the “yield curve” bouncing back nicely, does that mean the risk of a recession is receding? To find out, John Stepek looks to the charts that matter most to the global economy. 

Will China’s stockmarket bounce last?

Chinese stocks have staged an impressive rally, outperforming every other national index in the world in the first quarter of 2019. Can that continue?

British stocks are due a bounce

Uncertainty over Brexit has prompted consumers and companies to put off investing in British stocks. Once clarity returns, cheap stocks should rebound, says David Stevenson.

Steve Eisman: short Canada

Steve Eisman, the man who made his name by betting against the US housing market ahead of the subprime crash in 2008 now has Canada in his sites.

The charts that matter – a ray of hope in the US employment data

As US unemployment falls again, John Stepek looks at what it means for the markets and the global economy, plus a rundown of the rest of the charts that matter the most.

Turkey is in trouble again

Turkey’s currency has slipped to an eight-month low against the US dollar, after a 40% slump in the first half of last year. The economy shrank by 3% in the fourth quarter of 2018 and inflation has reached almost 20%.

Latest recession scare is a false alarm

Markets have been spooked by the inversion of the US bond yield curve, which often – but not always – heralds a recession.

Bayer’s Monsanto mess

German giant Bayer has made a pig’s ear of buying the US biotech Monsanto: the stock is wilting amid legal trouble over a weedkiller. Matthew Partridge reports.

Showing page 2 of 526